Tazarotene 0.045% Lotion for Truncal Acne: Efficacy, Tolerability, and Spreadability

Main Article Content

Leon Kircik
Zoe D Draelos
Eric Guenin

Keywords

tazarotene, lotion, truncal, acne, efficacy, spreadability, tolerability

References

1. Del Rosso JQ. Cutis. 2006;77:285–289

2. Dréno B, et al. JEADV. 2015;29(6):1096–1106

3. Poli F, et al. JEADV. 2020;34(10):2241–2246

4. Short RW, et al. Pediatr Dermatol. 25(1):126–128

5. Kim BR, et al. Dermatol. 231:87–93

6. Tanghetti EA, et al. J Dermatol Treat. 2019;Sept 26:1–8

7. Kircik LH, et al. J Dermatol Treat. 2021;Aug 30:1–9

8. Kircik LH. J Drugs Dermatol. 2022;21(7):713–716

9. Draelos ZD, et al. J Drugs Dermatol. 2021;21(3):250–257

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 > >>